BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36738552)

  • 21. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
    Costacou T; Saenger AK; Orchard TJ
    Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early markers of myocardial ischemia: from the experimental model to forensic pathology cases of sudden cardiac death.
    Sabatasso S; Moretti M; Mangin P; Fracasso T
    Int J Legal Med; 2018 Jan; 132(1):197-203. PubMed ID: 28497398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events.
    Gyanwali B; Lai MKP; Lui B; Liew OW; Venketasubramanian N; Richards AM; Chen C; Hilal S
    Stroke; 2021 Jul; 52(7):2275-2283. PubMed ID: 33971742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of proBNP and NT-proBNP in Sudden Death of Coronary Heart Disease].
    Zeng Q; Sun RF; Li Z; Zhai LQ; Liu MZ; Guo XJ; Gao CR
    Fa Yi Xue Za Zhi; 2017 Oct; 33(5):476-481. PubMed ID: 29275551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Instant rule-out of suspected non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponin T with Copeptin versus a single low high-sensitivity cardiac troponin T: findings from a large pooled individual data analysis on 10,329 patients.
    Giannitsis E; Huber K; Hamm CW; Möckel M
    Clin Res Cardiol; 2021 Feb; 110(2):194-199. PubMed ID: 32671467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of myocardial ischemia combining multiphase postmortem CT-angiography, histology, and postmortem biochemistry.
    Vanhaebost J; Ducrot K; de Froidmont S; Scarpelli MP; Egger C; Baumann P; Schmit G; Grabherr S; Palmiere C
    Radiol Med; 2017 Feb; 122(2):95-105. PubMed ID: 27766573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
    Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
    Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudden cardiac death and myocardial ischemia indicators: a comparative study of four immunohistochemical markers.
    Campobasso CP; Dell'Erba AS; Addante A; Zotti F; Marzullo A; Colonna MF
    Am J Forensic Med Pathol; 2008 Jun; 29(2):154-61. PubMed ID: 18520484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of forensic thanatology through the prism of analysis of postmortem protocols collected at the Department of Forensic Medicine, Jagiellonian University].
    Konopka T
    Arch Med Sadowej Kryminol; 2011; 61(3):213-300. PubMed ID: 22393873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
    Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T
    Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac biomarkers in pediatric CKD-a prospective follow-up study.
    Lindblad YT; Vavilis G; Chromek M; Quershi AR; Löwbeer C; Bárány P
    Pediatr Nephrol; 2022 Dec; 37(12):3165-3175. PubMed ID: 35294668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
    McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
    Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome.
    Myhre PL; Røsjø H; Sarvari SI; Ukkonen H; Rademakers F; Engvall JE; Hagve TA; Nagel E; Sicari R; Zamorano JL; Monaghan M; D'hooge J; Edvardsen T; Omland T
    Int J Cardiol; 2022 Aug; 361():14-17. PubMed ID: 35577165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Cardiac Injury Markers in the Postmortem Diagnosis of Sudden Cardiac Death.
    Carvajal-Zarrabal O; Hayward-Jones PM; Nolasco-Hipolito C; Barradas-Dermitz DM; Calderón-Garcidueñas AL; López-Amador N
    J Forensic Sci; 2017 Sep; 62(5):1332-1335. PubMed ID: 28111741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
    Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
    ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
    Januzzi JL; Butler J; Zannad F; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; Verma S; Vedin O; Iwata T; Brueckmann M; Packer M; Anker SD;
    JACC Heart Fail; 2022 Jul; 10(7):512-524. PubMed ID: 35670067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac troponin T determination by a highly sensitive assay in postmortem serum and pericardial fluid.
    González-Herrera L; Valenzuela A; Ramos V; Blázquez A; Villanueva E
    Forensic Sci Med Pathol; 2016 Jun; 12(2):181-8. PubMed ID: 26956978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic relevance of ischemia-modified albumin and NT-proBNP in patients with peripheral arterial occlusive disease.
    Falkensammer J; Frech A; Duschek N; Gasteiger S; Stojakovic T; Scharnagl H; Huber K; Fraedrich G; Greiner A
    Clin Chim Acta; 2015 Jan; 438():255-60. PubMed ID: 25195005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.